. . . . . . . . . . . . "[5alpha-reductase type 1 (5alphaR1) immunostaining is increased and 5alpha-reductase type 2 (5alphaR2) immunostaining is decreased during development of prostate cancer and there is increased expression of both in recurrent and metastatic cancers ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:32:57+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .